BIOMAT Database Logo BIOMAT Database Logo

Somatotrophic and corticotrophic functions in primary hypothyroidism before and after thyroxine treatment. 1973

M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Reappraisal of thyroxine treatment in primary hypothyroidism.
October 1990, Archives of disease in childhood,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Plasma total thyroxine and free thyroxine concentrations in congenital hypothyroidism before and during treatment.
September 1992, Journal of clinical pathology,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Human growth hormone secretion in primary hypothyroidism before and after treatment.
December 1967, The Journal of clinical endocrinology and metabolism,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.
January 1986, Postgraduate medical journal,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Thyroxine adherence in primary hypothyroidism.
May 2004, Lancet (London, England),
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy.
December 1996, Endocrine journal,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
[A central nerve conduction study in hypothyroidism: before and after thyroxine replacement].
December 1998, The Kaohsiung journal of medical sciences,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Reproductive endocrine functions in men with primary hypothyroidism: effect of thyroxine replacement.
January 1990, Hormone research,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Changes in cardiac function at rest before and after treatment in primary hypothyroidism.
February 2000, The American journal of cardiology,
M Minozzi, and M Faggiano, and G Lombardi, and C Carella, and T Criscuolo, and C Oliver, and P Vague
Serum thyroxine content before and after thyrotropin stimulation in dogs with suspected hypothyroidism.
July 1980, Journal of the American Veterinary Medical Association,
Copied contents to your clipboard!